Concepedia

Erick J. Morris

EJ

31

Publications

4.2K

Citations

27

H-Index

1995

Active since

Affiliations

Massachusetts General Hospital(Current)

Servier (France)

Novartis (Switzerland)

Columbia University

Harvard University

Erick J. Morris is an author at Massachusetts General Hospital specializing in medicine, cell biology, and cell death.

Top concepts

MedicineCell BiologyCell DeathApoptosisPharmacologyCell SignalingTumor BiologyRadiation OncologyHealthOncology

Publications per year

1995–2022

31

Publications

31

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

Pharmacotherapy, Tumor Biology, Drug Resistance +20

Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.

Erick J. Morris, Herbert M. Geller · The Journal of Cell Biology · 1996 · 308 citations · Full text

Apoptosis, Enzyme Dna Topoisomerase-i, Cell Death +17

E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8

Erick J. Morris, Jun‐Yuan Ji, Fajun Yang et al. · Nature · 2008 · 297 citations

Transcriptional Regulation, Signal Transduction, β-Catenin Transcription +9

G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis

David S. Park, Erick J. Morris, Lloyd A. Greene et al. · Journal of Neuroscience · 1997 · 275 citations · Full text

Apoptosis, Immunology, Cell Death +18

Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents

David S. Park, Erick J. Morris, Jaya Padmanabhan et al. · The Journal of Cell Biology · 1998 · 264 citations · Full text

Rows per page

1–5 of 31